Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Molecular Therapy. Methods & Clinical Development|May 28, 2015
Bioengineered coagulation factor VIII enables long-term correction of murine hemophilia A following liver-directed adeno-associated viral vector deliveryHarrison C Brown, J Fraser Wright, Shangzhen Zhou, et al.
The Journal of Gene Medicine|March 9, 2010
Functional aspects of factor VIII expression after transplantation of genetically-modified hematopoietic stem cells for hemophilia ALucienne M Ide, Neal N Iwakoshi, Bagirath Gangadharan, et al.
Human Gene Therapy|August 31, 2018
Preclinical Development of a Hematopoietic Stem and Progenitor Cell Bioengineered Factor VIII Lentiviral Vector Gene Therapy for Hemophilia AChristopher B Doering, Gabriela Denning, Jordan E Shields, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 5, 2009
Directed engineering of a high-expression chimeric transgene as a strategy for gene therapy of hemophilia AChristopher B Doering, Gabriela Denning, Kerry Dooriss, et al.
Human Gene Therapy|July 14, 2020
Development of a Clinical Candidate AAV3 Vector for Gene Therapy of Hemophilia BHarrison C Brown, Christopher B Doering, Roland W Herzog, et al.
Oncoimmunology|August 16, 2019
Ex vivo expanded patient-derived γδ T-cell immunotherapy enhances neuroblastoma tumor regression in a murine modelJaquelyn T Zoine, Kristopher A Knight, Lauren C Fleischer, et al.
Molecular Therapy. Methods & Clinical Development|February 25, 2016
Effects of FVIII immunity on hepatocyte and hematopoietic stem cell-directed gene therapy of murine hemophilia AAllison M Lytle, Harrison C Brown, Na Yoon Paik, et al.
Oncoimmunology|February 6, 2018
Development of chimeric antigen receptors targeting T-cell malignancies using two structurally different anti-CD5 antigen binding domains in NK and CRISPR-edited T cell linesSunil S Raikar, Lauren C Fleischer, Robert Moot, et al.
Cytotherapy|November 10, 2020
Bortezomib enhances cytotoxicity of ex vivo-expanded gamma delta T cells against acute myeloid leukemia and T-cell acute lymphoblastic leukemiaJamie Y Story, Jaquelyn T Zoine, Rebecca E Burnham, et al.
Oncoimmunology|April 4, 2022
Dissecting the cellular components of <i>ex vivo</i> γδ T cell expansions to optimize selection of potent cell therapy donors for neuroblastoma immunotherapy trialsHunter C Jonus, Rebecca E Burnham, Andrew Ho, et al.
Pageof 8